Home | Value-Based Care in Neurology

Featured Articles

Predicting the Onset of Alzheimer Disease Symptoms

Previous studies of in vitro and in vivo aggregation of β-amyloid have suggested that there is a tipping point above which aggregates become nuclei for further aggregation, which proceeds at a constant and predictable rate after the tipping point.

Read more
Psilocybin May Not Be More Efficacious Than a Common Antidepressant

The first-line treatment for major depressive disorder is a selective serotonin reuptake inhibitor, but not all patients respond to this treatment. Psilocybin, a psychedelic made by certain mushrooms, is one alternative that is receiving renewed interest.

Read more

Multiple Sclerosis

Risk Factors for COVID-19 Disease Severity in Patients with Multiple Sclerosis in North America

Comparison of Relapse Rates for Disease-Modifying Therapies for Multiple Sclerosis Using Real-World Data

Intramuscular Injection Form of Peginterferon Beta-1a Approved for Use in Treating Relapsing Multiple Sclerosis

View More Articles

COVID-19

Use of Functional MRI in a Patient Diagnosed with COVID-19 Experiencing Olfactory and Gustatory Symptoms

The Effect of Disease-Modifying Therapies on the Immune System in Patients with Multiple Sclerosis: Impact on COVID-19 Infection and Vaccination

Immune Reaction to COVID-19 May Play a Role in the Clinical Onset of Multiple Sclerosis

View More Articles